机译:BCR的快速减少 - ABL1 BCR BCR - ABL ABL1转录物预测Dasatinib治疗的慢性相慢性骨髓单细胞白血病患者的深层分子反应
Division of Hematology and OncologyIwate Medical University School of MedicineMorioka Japan;
Department of HematologyAomori Prefectural Central HospitalAomori Japan;
Department of Clinical OncologyIwate Medical UniversityMorioka Japan;
Department of Internal MedicineKushiro Rosai HospitalKushiro Japan;
Division of Gastroenterology and Hematology/OncologyAsahikawa Medical UniversityAsahikawa Japan;
Division of HematologyHokkaido P.W.F.A.C. Obihiro‐Kosei General HospitalObihiro Japan;
Division of HematologyNational Hospital Organization Sendai Medical CenterSendai Japan;
Department of Internal MedicineKitami Red Cross HospitalKitami Japan;
Department of HematologyHokkaido UniversitySapporo Japan;
Division of HematologyKaisei HospitalSapporo Japan;
Department of HematologySapporo City General HospitalSapporo Japan;
Department of HematologyHokkaido Cancer CenterSapporo Japan;
Division of Hematology and OncologyIwate Medical University School of MedicineMorioka Japan;
Division of Hematology and OncologyIwate Medical University School of MedicineMorioka Japan;
Division of Hematology and OncologyIwate Medical University School of MedicineMorioka Japan;
Division of Hematology and OncologyIwate Medical University School of MedicineMorioka Japan;
Division of Gastroenterology and Hematology/OncologyAsahikawa Medical UniversityAsahikawa Japan;
Department of Cardiology and HematologyFukushima Medical UniversityFukushima Japan;
Department of HematologySaitama Medical UniversityKawagoe Japan;
Department of Internal MedicineNihonkai General HospitalSakata Japan;
Department of HematologyOkitama Public General HospitalKawanishimachi Higashi Okitama‐gun Japan;
Department of Neurology Hematology Metabolism and Diabetology (DNHMED)Yamagata University;
Department of Internal MedicineNiigata Cancer Center HospitalNiigata Japan;
Department of HematologyAomori Prefectural Central HospitalAomori Japan;
Department of BiostatisticsThe University of TokyoTokyo Japan;
Tokai Central HospitalKakamigahara Japan;
Division of Hematology and OncologyIwate Medical University School of MedicineMorioka Japan;
chronic myeloid leukaemia; deep molecular response; tyrosine kinase inhibitors;
机译:BCR的快速减少 - ABL1 BCR BCR - ABL ABL1转录物预测Dasatinib治疗的慢性相慢性骨髓单细胞白血病患者的深层分子反应
机译:Dasatinib迅速诱导慢性相慢性骨髓白血病患者的深层分子响应,其通过伊马替尼治疗实现了具有可检测水平的BCR-Abl1转录物的主要分子响应
机译:BCR-ABL1转录物的减半时间缩短是达沙替尼治疗的新诊断的慢性期慢性粒细胞白血病中分子反应实现的新预测因子:关东CML研究组的D-first研究结果
机译:尼日利亚慢性粒细胞白血病患者唾液中BCR-ABL1融合基因的检测与定量
机译:载有siRNA的纳米颗粒抑制BCR-ABL用于治疗慢性粒细胞白血病
机译:达沙替尼可快速诱导慢性阶段性髓样白血病患者的深层分子反应这些患者通过伊马替尼治疗可达到可检测水平的BCR-ABL1转录本从而达到主要分子反应
机译:慢性粒细胞白血病患者随访中乳酸脱氢酶(LDH)和 Bcr-abl em>转录物的测定 b> - doi:10.4025 / actascihealthsci.v32i2.6408 慢性粒细胞白血病患者随访中乳酸脱氢酶(LDH)和 Bcr-abl em>转录本的测定 b> - doi:10.4025 / actascihealthsci.v32i2.6408